메뉴 건너뛰기




Volumn 49, Issue 7, 2009, Pages 1412-1422

Universal adoption of pathogen inactivation of platelet components: Impact on platelet and red blood cell component use

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD BANK; BLOOD COMPONENT; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE TRANSFUSION;

EID: 67649985872     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02151.x     Document Type: Article
Times cited : (75)

References (18)
  • 1
    • 67649984773 scopus 로고    scopus 로고
    • Blood manufacturing: Component preparation, storage, and transportation
    • In. Hillyer, C.D. Silberstein, L.E. Ness, P.M. Anderson, K.C. Roback, J.D. editors. ed. Philadelphia (PA). Churchill Livingstone. p.
    • Harris SB, Hillyer CD. Blood manufacturing: component preparation, storage, and transportation. In : Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, editors. Blood banking and transfusion medicine. 2nd ed. Philadelphia (PA) : Churchill Livingstone 2007. p. 183 204.
    • (2007) Blood Banking and Transfusion Medicine. 2nd , pp. 183-204
    • Harris, S.B.1    Hillyer, C.D.2
  • 4
    • 2642611953 scopus 로고    scopus 로고
    • Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions
    • TRAP Study Group.
    • TRAP Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 337 : 1861 9.
    • (1997) N Engl J Med , vol.337 , pp. 1861-9
  • 5
    • 0042845841 scopus 로고    scopus 로고
    • Prophylactic platelet transfusions: Which dose is the best dose? A review of the literature
    • Tinmouth AT, Freedman J. Prophylactic platelet transfusions: which dose is the best dose? A review of the literature. Transfus Med Rev 2003 17 : 181 93.
    • (2003) Transfus Med Rev , vol.17 , pp. 181-93
    • Tinmouth, A.T.1    Freedman, J.2
  • 6
    • 33745153101 scopus 로고    scopus 로고
    • Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients
    • Slichter SJ. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. J Clin Apher 2006 21 : 78 84.
    • (2006) J Clin Apher , vol.21 , pp. 78-84
    • Slichter, S.J.1
  • 7
    • 42949159998 scopus 로고    scopus 로고
    • Evidence-based platelet transfusion guidelines
    • In. Gewirtz, A.M. Winter, J.N. Zuckerman, K. editors. Washington, DC. American Society of Hematology. p.
    • Slichter SJ. Evidence-based platelet transfusion guidelines. In : Gewirtz AM, Winter JN, Zuckerman K, editors. American Society of Hematology education program book. Washington, DC : American Society of Hematology 2007. p. 172 8.
    • (2007) American Society of Hematology Education Program Book. , pp. 172-8
    • Slichter, S.J.1
  • 9
    • 36649022874 scopus 로고    scopus 로고
    • Proceedings of a consensus conference: Pathogen inactivation-making decisions about new technologies. Clinical experience with pathogen-inactivated platelets
    • Cazenave JP. Proceedings of a consensus conference: pathogen inactivation-making decisions about new technologies. Clinical experience with pathogen-inactivated platelets. Transfusion Med Reviews 2008 22 : 1 34.
    • (2008) Transfusion Med Reviews , vol.22 , pp. 1-34
    • Cazenave, J.P.1
  • 16
    • 33644841313 scopus 로고    scopus 로고
    • Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: An analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light
    • DOI 10.1111/j.1537-2995.2005.00671.x
    • Murphy S, Snyder E, Cable R, Slichter SJ, Strauss RG, McCullough J, Lin JS, Corash L, Conlan MG SPRINT Study Group. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light. Transfusion 2006 46 : 24 33. (Pubitemid 43381781)
    • (2006) Transfusion , vol.46 , Issue.1 , pp. 24-33
    • Murphy, S.1    Snyder, E.2    Cable, R.3    Slichter, S.J.4    Strauss, R.G.5    McCullough, J.6    Lin, J.-S.7    Corash, L.8    Conlan, M.G.9
  • 18


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.